Andrew Sindone ⁎, , Mikhail Kosiborod , Mark C Petrie , Barry A Borlaug , Javed Butler , Melanie J Davies , G. Kees Hovingh , Dalane W Kitzman , Daniél Vega Møller , Marianne Bach Treppendahl , Subodh Verma , Thomas J Jensen , Karoline Liisberg , Marie L Lindegaard , Sanjiv J Shah
{"title":"射血分数保留型心力衰竭、肥胖和 2 型糖尿病患者每周一次服用塞马鲁肽:STEP-HFpEF DM 试验的主要结果","authors":"Andrew Sindone ⁎, , Mikhail Kosiborod , Mark C Petrie , Barry A Borlaug , Javed Butler , Melanie J Davies , G. Kees Hovingh , Dalane W Kitzman , Daniél Vega Møller , Marianne Bach Treppendahl , Subodh Verma , Thomas J Jensen , Karoline Liisberg , Marie L Lindegaard , Sanjiv J Shah","doi":"10.1016/j.orcp.2024.09.085","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19408,"journal":{"name":"Obesity research & clinical practice","volume":"18 5","pages":"Page S37"},"PeriodicalIF":2.5000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes: main results from the STEP-HFpEF DM trial\",\"authors\":\"Andrew Sindone ⁎, , Mikhail Kosiborod , Mark C Petrie , Barry A Borlaug , Javed Butler , Melanie J Davies , G. Kees Hovingh , Dalane W Kitzman , Daniél Vega Møller , Marianne Bach Treppendahl , Subodh Verma , Thomas J Jensen , Karoline Liisberg , Marie L Lindegaard , Sanjiv J Shah\",\"doi\":\"10.1016/j.orcp.2024.09.085\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19408,\"journal\":{\"name\":\"Obesity research & clinical practice\",\"volume\":\"18 5\",\"pages\":\"Page S37\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obesity research & clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1871403X24001856\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity research & clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871403X24001856","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes: main results from the STEP-HFpEF DM trial
期刊介绍:
The aim of Obesity Research & Clinical Practice (ORCP) is to publish high quality clinical and basic research relating to the epidemiology, mechanism, complications and treatment of obesity and the complication of obesity. Studies relating to the Asia Oceania region are particularly welcome, given the increasing burden of obesity in Asia Pacific, compounded by specific regional population-based and genetic issues, and the devastating personal and economic consequences. The journal aims to expose health care practitioners, clinical researchers, basic scientists, epidemiologists, and public health officials in the region to all areas of obesity research and practice. In addition to original research the ORCP publishes reviews, patient reports, short communications, and letters to the editor (including comments on published papers). The proceedings and abstracts of the Annual Meeting of the Asia Oceania Association for the Study of Obesity is published as a supplement each year.